Ja Young Seo

Ja Young Seo

Auto-generated profile, based on publicly available information

Ja Young Seo

Department of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon 21565, Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JJJi Hun Jeong
Ji Hun Jeong
YSYiel Hea Seo
Yiel Hea Seo
JAJeong Yeal Ahn
Jeong Yeal Ahn
KKKyung-hee Kim
Kyung-hee Kim
JSJa Young Seo
Ja Young Seo
PPPil Whan Park
Pil Whan Park
Jeong JH, et al. Ann Lab Med. 2020 Jan;40(1):7-14. https://doi.org/10.3343/alm.2020.40.1.7

21 August 2021 in World Journal of Gastroenterology
Verified
Journal Article
Open access
Youn I ChoiYoun I Choi
Youn I Choi
JCJun-Won Chung
Jun-Won Chung
KKKyoung Oh Kim
Kyoung Oh Kim
KKKwang An Kwon
Kwang An Kwon
YKYoon Jae Kim
Yoon Jae Kim
DPDong Kyun Park
Dong Kyun Park
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients

1 March 2021 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JSJa Young Seo
Ja Young Seo
JAJeong-Yeal Ahn
Jeong-Yeal Ahn
BKBhumsuk Keam
Bhumsuk Keam
MKMiso Kim
Miso Kim
SYShinkyo Yoon
Shinkyo Yoon
PHPh.D.
Ph.D.
Ja Young Seo, M.D., Ph.D., Jeong-Yeal Ahn, M.D., Ph.D., Bhumsuk Keam, M.D., Ph.D., Miso Kim, M.D., Shinkyo Yoon, M.D., Ph.D., Jae Lyun Lee, M.D., Ph.D., Kwonoh Park, M.D., Ph.D., and Inkeun Park, M.D., Ph.D.. Ann Lab Med 2021;41:207-13. https://doi.org/10.3343/alm.2021.41.2.207

16 May 2022 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
GPGeu-Meum Park
Geu-Meum Park
SLSoo Jung Lee
Soo Jung Lee
JSJa Young Seo
Ja Young Seo
KLKyung In Lim
Kyung In Lim
Maturity-onset diabetes of the young (MODY) is a rare, autosomal dominant disease characterized by non-ketogenic diabetes mellitus (DM). MODY type 4, caused by PDX1 mutation, is a very rare subtype of MODY, especially in Korea. We report a case of a 10-year-old, nonobese girl with a family history of type 2 DM. After diagnosis, the patient’s serum glucose level was well controlled using metformin monotherapy; however, the glycated hemoglobin level increased to 9.0% approximately 2 years after treatment. No obesity or lifestyle problems were observed, and serum fasting C-peptide level was within the normal range. Furthermore, no islet-related autoantibodies were detected. A genetic screening for MODY using a next-generation sequencing panel was performed, and a likely heterozygous pathogenic PDX1 mutation (p.Gly246ArgfsTer21) was identified. The PDX1 variant was not detected in her mother, implying that the mutation had arisen de novo in the proband. She was prescribed insulin degludec in addition to metformin therapy, which improved her hyperglycemia. This report presents a novel MODY type 4 phenotype and highlights the importance of genetic screening in patients with MODY characteristics.

2 February 2023 in Laboratory Medicine
Verified
Journal Article
Closed access
PDF file
HLHwan Tae Lee
Hwan Tae Lee
SLSo Young Lee
So Young Lee
JSJa Young Seo
Ja Young Seo
JAJeong-Yeal Ahn
Jeong-Yeal Ahn
Objective: Modular workcells could be a better solution than total laboratory automation (TLA) in hemostasis laboratories. Here, we evaluated the impact of implementing a modular workcell (HemoCell) with an intelligent data management facility (HemoHub). Methods: We compared the turnaround times (TATs), numbers of rerun samples, and rerun times pre- and postimplementation of the HemoCell at Gil Medical Center. Prothrombin time (PT), activated partial thromboplastin time (aPTT), D-dimer, and fibrinogen were evaluated. Results: The TAT standard deviations (SDs) and maximum TAT values decreased after HemoCell implementation, although the mean TATs for PT, aPTT, and D-dimer were increased. Numbers of rerun samples were increased (18.1/day vs 44.7/day). However, rerun times were reduced, and SDs were decreased during the post-HemoCell period compared with pre-HemoCell. Additionally, technologists needed smaller working space and less labor. Conclusion: The modular workcell could improve quality and efficiency by providing more consistent TATs and shorter rerun times in the hemostasis laboratory.

13 October 2025 in Biology
Verified
Journal Article
Open access
PDF file
WKWoo Jin Kim
Woo Jin Kim
CHChorong Hahm
Chorong Hahm
DKDongin Kim
Dongin Kim
DKDaewon Kim
Daewon Kim
JSJa Young Seo
Ja Young Seo
JLJOOHEE LEE
JOOHEE LEE
The monitoring and surveillance of antimicrobial resistance (AMR) is an important procedure in clinical patient management and epidemiological public health. Conventionally, culture-based tools such as disk diffusion methods or broth dilution methods for antibiotic susceptibility tests are used. While culture-independent approaches, such as PICRUSt2, Tax4Fun, or MicFunPred, have recently been tried based on predictive functional profiling using the 16S rRNA marker gene, evaluations of AMR tools are scarce. A total of 20 E. coli strains (Carbapenem-resistant (CRE) positive: 10, CRE negative: 10) were used. The AMR phenotype was based on Vitek2 (bioMerieux). DNA was extracted from the 20 strains, and 16S rRNA (V3-V4 region) and shotgun sequencing was carried out. The bioinformatic pipelines were QIIM2 for 16S rRNA and MetaPhlAn4 for shotgun. The functional prediction tools were PICRUSt2, Tax4Fun, and MicFunPred for 16S rRNA and AMRFinderPlus for shotgun. The presence/absence of 23 KEGG numbers regarding AMR in PICRUSt2, Tax4Fun, and MicFunPred were compared to shotgun AMR profiles. The F1 scores were calculated according to each 16S marker gene-based prediction tool using a confusion matrix. A total of 12 classes of antibiotics, including carbapenem, were analyzed. The F1 scores of 16S predictive functional profilers regarding AMR were 0.22 for Tax4Fun, 0.12 for PICRUSt2, and 0.08 for MicFunPred. While Tax4Fun showed the highest F1 score of the three 16S predictive functional profilers, the F1 scores were generally low. Our study highlights the necessity of integrating specialized AMR databases and improving algorithmic approaches to achieve meaningful accuracy in resistance prediction.